Sharifian A, Pourhoseingholi MA, Emadedin M, et al. Burden of breast cancer in Iranian women is increasing. Asian Pac J Cancer Prev. 2015;16(12):5049–52.

Article  PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Higgins MJ, Baselga J. Targeted therapies for breast cancer. J Clin Investig. 2011;121(10):3797–803.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qi C-J, Ning Y-L, Han Y-S, et al. Autologous dendritic cell vaccine for estrogen receptor (ER)/progestin receptor (PR) double-negative breast cancer. Cancer Immunol Immunother. 2012;61(9):1415–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lam Q, Lu L. Role of leptin in immunity. Cell Mol Immunol. 2007;4(1):1–13.

CAS  PubMed  Google Scholar 

Procaccini C, Jirillo E, Matarese G. Leptin as an immunomodulator. Mol Aspects Med. 2012;33(1):35–45.

Article  CAS  PubMed  Google Scholar 

Lam QLK, Zheng B-J, Jin D-Y, et al. Leptin induces CD40 expression through the activation of Akt in murine dendritic cells. J Biol Chem. 2007;282(38):27587–97.

Article  CAS  PubMed  Google Scholar 

White SJ, Taylor MJ, Hurt RT, et al. Leptin-based adjuvants: an innovative approach to improve vaccine response. Vaccine. 2013;31(13):1666–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li M, Knight DA, Snyder LA, et al. A role for CCL2 in both tumor progression and immunosurveillance. Oncoimmunology. 2013;2(7):e25474.

Article  PubMed  PubMed Central  Google Scholar 

Bonapace L, Coissieux M-M, Wyckoff J, et al. Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis. Nature. 2014;515(7525):130–3.

Article  CAS  PubMed  Google Scholar 

Velasco-Velázquez M, Xolalpa W, Pestell RG. The potential to target CCL5/CCR5 in breast cancer. Expert Opin Ther Targets. 2014;18(11):1265–75.

Article  PubMed  Google Scholar 

Aldinucci D, Casagrande N. Inhibition of the CCL5/CCR5 axis against the progression of gastric cancer. Int J Mol Sci. 2018;19(5):1477.

Article  PubMed  PubMed Central  Google Scholar 

Shibata M, Kono K, Takenoshita S. Inhibiting VEGF in cancer immunotherapy. Clinical Immunology Communications. 2022;2:12–6.

Article  CAS  Google Scholar 

Gao H, Lan X, Li S, et al. Relationships of MMP-9, E-cadherin, and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer. Tumor Biology. 2017;39(5):1010428317698368.

Article  PubMed  Google Scholar 

Augoff K, Hryniewicz-Jankowska A, Tabola R, et al. MMP9: a tough target for targeted therapy for cancer. Cancers. 2022;14(7):1847.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hirano T, Ishihara K, Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene. 2000;19(21):2548–56.

Article  CAS  PubMed  Google Scholar 

Tawara K, Scott H, Emathinger J, et al. Co-expression of VEGF and IL-6 family cytokines is associated with decreased survival in HER2 negative breast cancer patients: subtype-specific IL-6 family cytokine-mediated VEGF secretion. Transl Oncol. 2019;12(2):245–55.

Article  PubMed  Google Scholar 

Jiang W, Lian J, Yue Y, et al. IL-33/ST2 as a potential target for tumor immunotherapy. Eur J Immunol. 2021;51(8):1943–55.

Article  CAS  PubMed  Google Scholar 

Wasmer M-H, Krebs P. The role of IL-33-dependent inflammation in the tumor microenvironment. Front Immunol. 2017;7:682.

Article  PubMed  PubMed Central  Google Scholar 

Yang Q, Li G, Zhu Y, et al. IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells. Eur J Immunol. 2011;41(11):3351–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao X, Wang X, Yang Q, et al. Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells. J Immunol. 2015;194(1):438–45.

Article  CAS  PubMed  Google Scholar 

Chen J, Zhao Y, Jiang Y, et al. Interleukin-33 contributes to the induction of Th9 cells and antitumor efficacy by dectin-1-activated dendritic cells. Front Immunol. 2018;9:1787.

Article  PubMed  PubMed Central  Google Scholar 

Xu L, Zheng Y, Wang J, et al. IL33 activates CD8+ T and NK cells through MyD88 pathway to suppress the lung cancer cell growth in mice. Biotech Lett. 2020;42:1113–21.

Article  CAS  Google Scholar 

Basirjafar P, Zandvakili R, Masoumi J, et al. Leptin/lipopolysaccharide-treated dendritic cell vaccine improved cellular immune responses in an animal model of breast cancer. Immunopharmacol Immunotoxicol. 2024;46(1):73–85.

Article  CAS  PubMed  Google Scholar 

Masoumi J, Jafarzadeh A, Tavakoli T, et al. Inhibition of apelin/APJ axis enhances the potential of dendritic cell-based vaccination to modulate TH1 and TH2 cell-related immune responses in an animal model of metastatic breast cancer. Adv Med Sci. 2022;67(1):170–8.

Article  CAS  PubMed  Google Scholar 

Zandvakili R, Basirjafar P, Masoumi J, et al. Vaccination with celecoxib-treated dendritic cells improved cellular immune responses in an animal breast cancer model. Adv Med Sci. 2023;68(1):157–68.

Article  CAS  PubMed  Google Scholar 

Jadidi-Niaragh F, Atyabi F, Rastegari A, et al. CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice. J Control Release. 2017;246:46–59.

Article  CAS  PubMed  Google Scholar 

Mattioli B, Straface E, Quaranta MG, et al. Leptin promotes differentiation and survival of human dendritic cells and licenses them for Th1 priming. J Immunol. 2005;174(11):6820–8.

Article  CAS  PubMed  Google Scholar 

Zhou J, Xi Y, Mu X, et al. Antitumor immunity induced by VE-cadherin modified DC vaccine. Oncotarget. 2017;8(40):67369.

Article  PubMed  PubMed Central  Google Scholar 

Zhang S-N, Choi I-K, Huang J-H, et al. Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF. Mol Ther. 2011;19(8):1558–68.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yan Z, Huimin W, Zhong H. Metronomic chemotherapy combined with dendritic cell vaccine inhibits VEGF secretion. CJLC. 2013;16(9):460–3.

CAS  Google Scholar 

Mehner C, Hockla A, Miller E, et al. Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer. Oncotarget. 2014;5(9):2736.

Article  PubMed  PubMed Central  Google Scholar